Biomarin Pharmaceutical Inc

Allworth Financial LP BMRN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/5/2026

Shares

5,090

Value ($000)

302

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/5/2026	302	0.0%	5,090	12/31/2025
2025 Q2	8/7/2025	145	0.0%	2,644	6/30/2025
2025 Q1	4/30/2025	112	0.0%	1,793	3/31/2025
2024 Q4	1/30/2025	118	0.0%	1,904	12/31/2024
2024 Q3	10/23/2024	125	0.0%	1,777	9/30/2024
2024 Q2	7/24/2024	165	0.0%	1,968	6/30/2024
2024 Q1	4/25/2024	172	0.0%	1,964	3/31/2024
2023 Q4	1/24/2024	58	0.0%	604	12/31/2023
2023 Q3	10/31/2023	35	0.0%	390	9/30/2023
2023 Q2	7/18/2023	30	0.0%	346	6/30/2023
2023 Q1	4/18/2023	35	0.0%	356	3/31/2023
2022 Q4	1/13/2023	23	0.0%	226	12/31/2022
2022 Q3	11/14/2022	17	0.0%	199	9/30/2022
2022 Q2	7/13/2022	13	0.0%	160	6/30/2022
2022 Q1	4/22/2022	20	0.0%	262	3/31/2022
2021 Q4	1/21/2022	23	0.0%	262	12/31/2021
2021 Q3	11/2/2021	20	0.0%	262	9/30/2021
2021 Q2	8/2/2021	11	0.0%	136	6/30/2021
2021 Q1	4/29/2021	12	0.0%	161	3/31/2021
2020 Q4	1/26/2021	12	0.0%	140	12/31/2020
2020 Q3	11/3/2020	11	0.0%	140	9/30/2020
2020 Q2	7/24/2020	14	0.0%	115	6/30/2020
2020 Q1	4/17/2020	10	0.0%	115	3/31/2020
2019 Q4	1/16/2020	10	0.0%	115	12/31/2019